Cancer drug shows promise against rare joint tumors
NCT ID NCT01207492
First seen Feb 28, 2026 · Last updated May 08, 2026 · Updated 8 times
Summary
This study tested nilotinib, a drug used for leukemia, in 17 people with a rare joint tumor called PVNS (or giant cell tumor) that had come back or spread. The goal was to see if the drug could stop the tumor from growing or improve symptoms. Results focused on how long the tumor stayed stable and whether it shrank.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TENOSYNOVIAL GIANT CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
-
H. Lee Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Sarcoma Oncology Center
Santa Monica, California, 90403, United States
-
Stanford University Medical Center
Stanford, California, 94305, United States
-
UT MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.